Welcome to our dedicated page for Alchemy Investments Acquisition 1 SEC filings (Ticker: ALCUF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Alchemy Investments Acquisition 1's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Alchemy Investments Acquisition 1's regulatory disclosures and financial reporting.
Alchemy Investments Acquisition Corp 1 (ALCUF), a SPAC, reported a net loss of $639,568 for the six months ended June 30, 2026, compared with $521,753 a year earlier, driven by operating costs and related-party interest, with no operating revenues.
Cash outside the trust was only $18,995 and the working capital deficit was $4,363,815, while $9,103,236 remained in the Trust Account, including extension deposits. Management states there is substantial doubt about continuing as a going concern absent completion of a business combination by the extended deadline of September 9, 2026.
The company has a signed Business Combination Agreement to acquire Cartiga, LLC at an equity value of $540,000,000 via an Up‑C structure, subject to conditions including at least $40,000,000 of Available Closing Buyer Cash (which Cartiga can waive with sponsor share forfeitures). Nasdaq has begun delisting proceedings; ALCUF securities now trade over the counter.
Alchemy Investments Acquisition Corp 1 filed a notice that its Quarterly Report on Form 10-Q for the period ended June 30, 2026 will be filed late. The company states it could not complete the report without unreasonable effort or expense and is relying on Rule 12b-25 to extend the deadline.
The company expects to file the Form 10-Q within five calendar days of the prescribed due date. It indicates that all other required periodic reports over the past 12 months have been filed and that it does not anticipate any significant change in results of operations compared with the corresponding period of the prior year.
Alchemy Investments Acquisition Corp 1, a SPAC, has called a 2026 general meeting on September 1, 2026 to ask holders to approve an Extension Proposal that would move its deadline to complete the proposed business combination with Cartiga, LLC from September 9, 2026 to September 9, 2027. The SPAC has signed a Business Combination Agreement under an “Up-C” structure in which a Delaware corporation, Cartiga Holdings, Inc., would become the public parent of Cartiga.
If the Extension Proposal is approved, the sponsor will loan to the company the lesser of $30,000 or $0.03 per non‑redeemed Class A share for each month extended, depositing these amounts into the Trust Account as contributions repayable only if the business combination closes. As of July 29, 2026, the Trust Account held $9,149,396.62, or about $12.41 per Public Share.
Public shareholders may redeem all or part of their Public Shares for their pro rata share of the Trust Account in connection with the Extension, regardless of how they vote. If the Extension is not approved and no business combination is completed by the current deadline, the company will redeem 100% of Public Shares and liquidate, leaving the warrants worthless. The proxy also seeks ratification of CBIZ CPAs P.C. as auditor for 2026 and approval of an Adjournment Proposal.
Alchemy Investments Acquisition Corp 1 is calling a 2026 annual general meeting on September 1, 2026 to ask shareholders to extend the deadline to complete its proposed business combination with Cartiga, LLC from September 9, 2026 to September 9, 2027. The extension would occur month-to-month, with the sponsor lending the lesser of $30,000 or $0.03 per non-redeemed Class A share into the trust account for each additional month, repayable only if a business combination closes.
Shareholders will also vote on ratifying CBIZ CPAs P.C. as auditor for 2026 and on an adjournment authority. Public shareholders may redeem some or all Class A shares in connection with the extension. If the extension is not approved and no deal closes by the current deadline, ALCY plans to redeem 100% of public shares and liquidate the SPAC. The trust account held about $9,114,765.64 as of July 14, 2026, and 4,208,043 ordinary shares were outstanding on the July 21, 2026 record date. ALCY’s securities were suspended from Nasdaq in May 2026 and now trade on the OTC Pink market.
Alchemy Investments Acquisition Corp 1 notified Nasdaq Stock Market LLC that its Class A Ordinary Shares, Units, and Warrants are being removed from listing and/or withdrawn from registration. The Exchange certified the action pursuant to 17 CFR 240.12d2-2(b) and the issuer confirmed voluntary withdrawal pursuant to 17 CFR 240.12d2-2(c).
The notification identifies Nasdaq as the Exchange and lists the issuer's principal office at 850 Library Avenue, Suite 204-F, Newark, Delaware 19711.
Alchemy Investments Acquisition Corp 1 reported a Q1 2026 net loss of $331,900 as it continues to search for a target and close its announced merger with Cartiga.
The SPAC held $8.96 million in its Trust Account and only $86,243 in cash outside the trust, resulting in a working capital deficit of $3.91 million and substantial doubt about its ability to continue as a going concern without completing a deal.
Alchemy has a Business Combination Agreement to acquire Cartiga at an equity value of $540 million using an Up‑C structure, with closing conditioned on shareholder approvals, a Nasdaq listing and at least $40 million of available closing cash unless waived. Sponsor loans totaled $2.0 million and the company continues making monthly deposits to extend its deadline to complete a transaction to September 9, 2026.